LYKA LABS Financial Statement Analysis
|
||
The Revenues of LYKA LABS have increased by 125.02% YoY .
The Earnings Per Share (EPS) of LYKA LABS has decreased by Negative YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
LYKA LABS Last 5 Annual Financial Results
[BOM: 500259|NSE : LYKALABS]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹194 Cr | ₹86 Cr | ₹61 Cr | ₹71 Cr | ₹60 Cr |
Expenses | ₹93 Cr | ₹67 Cr | ₹65 Cr | ₹73 Cr | ₹63 Cr |
Operating Profit (Excl OI) | ₹101 Cr | ₹20 Cr | ₹-3.67 Cr | ₹-1.90 Cr | ₹-3.55 Cr |
Other Income | ₹2.09 Cr | ₹1.56 Cr | ₹3.09 Cr | ₹2.09 Cr | ₹2.13 Cr |
Interest | ₹20 Cr | ₹26 Cr | ₹20 Cr | ₹7.17 Cr | ₹9.58 Cr |
Depreciation | ₹17 Cr | ₹8.32 Cr | ₹8.01 Cr | ₹7.31 Cr | ₹11 Cr |
Profit Before Tax | ₹59 Cr | ₹-14 Cr | ₹-62 Cr | ₹-15 Cr | ₹-20 Cr |
Profit After Tax | ₹38 Cr | ₹-10 Cr | ₹-63 Cr | ₹-6.35 Cr | ₹-19 Cr |
Consolidated Net Profit | ₹39 Cr | ₹-12 Cr | ₹-61 Cr | ₹-5.55 Cr | ₹-17 Cr |
Earnings Per Share (Rs) | ₹-4.30 | ₹13.59 | ₹-4.03 | ₹-21.10 | ₹-1.97 |
PAT Margin (%) | -14.13 | 19.81 | -11.70 | -101.84 | -8.97 |
ROE(%) | -63.63 | 0.00 | 0.00 | -448.65 | -14.20 |
ROCE(%) | -1.00 | 56.68 | 8.95 | -31.39 | -5.50 |
Total Debt/Equity(x) | 2.58 | 9.76 | -6.30 | -9.85 | 2.28 |
Key Financials |
||
Market Cap | : | ₹ 378.5 Cr |
Revenue (TTM) | : | ₹ 105.7 Cr |
Net Profit(TTM) | : | ₹ -3.5 Cr |
EPS (TTM) | : | ₹ -1.1 |
P/E (TTM) | : | - |
Industry Peers & Returns | 1W | 1M | 1Y |
LYKA LABS | -2% | -11.4% | 14.3% |
SUN PHARMACEUTICAL INDUSTRIES | 0.7% | -4.8% | 57.3% |
CIPLA | 1.9% | -2.4% | 42.6% |
DR REDDYS LABORATORIES | -5.4% | -4.1% | 20% |
ZYDUS LIFESCIENCES | 1.3% | 0.5% | 87.4% |
DIVIS LABORATORIES | 0.1% | 3% | 12.1% |
MANKIND PHARMA | -1.7% | -7.8% | 57.2% |
TORRENT PHARMACEUTICALS | -0.5% | 1% | 57.7% |
LUPIN | 4.8% | 5.2% | 115.9% |
LYKA LABS Revenues
[BOM: 500259|NSE : LYKALABS]
Y-o-Y | 125.02 % |
5 Yr CAGR | 34.22 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹194 Cr | 125.02 | |
Mar2022 | ₹86 Cr | 40.27 | |
Mar2021 | ₹61 Cr | -13.13 | |
Mar2020 | ₹71 Cr | 18.35 | |
Mar2019 | ₹60 Cr | - |
LYKA LABS Operating Profit
[BOM: 500259|NSE : LYKALABS]
Y-o-Y | 413.90 % |
5 Yr CAGR | Positive |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹101 Cr | 413.90 | |
Mar2022 | ₹20 Cr | Positive | |
Mar2021 | ₹-3.67 Cr | Negative | |
Mar2020 | ₹-1.90 Cr | Negative | |
Mar2019 | ₹-3.55 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 128.40 % |
5 Yr CAGR | Positive |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 52.12% | 128.40 | |
Mar2022 | 22.82% | Positive | |
Mar2021 | -5.97% | Negative | |
Mar2020 | -2.68% | Negative | |
Mar2019 | -5.94% | - |
LYKA LABS Profit After Tax
[BOM: 500259|NSE : LYKALABS]
Y-o-Y | Positive |
5 Yr CAGR | Positive |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹39 Cr | Positive | |
Mar2022 | ₹-12 Cr | Negative | |
Mar2021 | ₹-61 Cr | Negative | |
Mar2020 | ₹-5.55 Cr | Negative | |
Mar2019 | ₹-17 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | -14.13 % | Negative | |
Mar2022 | 19.81 % | Positive | |
Mar2021 | -11.7 % | Negative | |
Mar2020 | -101.84 % | Negative | |
Mar2019 | -8.97 % | - |
LYKA LABS Earnings Per Share (EPS)
[BOM: 500259|NSE : LYKALABS]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹-4.30 | Negative | |
Mar2022 | ₹14 | Positive | |
Mar2021 | ₹-4.03 | Negative | |
Mar2020 | ₹-21 | Negative | |
Mar2019 | ₹-1.97 | - |
LYKA LABS Return on Capital Employed (ROCE)
[BOM: 500259|NSE : LYKALABS]
Y-o-Y | Negative |
5 Yr CAGR | Negative |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | -1% | Negative | |
Mar2022 | 56.68% | 533.30 | |
Mar2021 | 8.95% | Positive | |
Mar2020 | -31.39% | Negative | |
Mar2019 | -5.5% | - |
LYKA LABS Share Price vs Sensex
Current Share Price | : | ₹114.4 |
Current MarketCap | : | ₹ 378.5 Cr |
Updated EOD on | : | May 13,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -2% |
-11.4% |
14.3% |
SENSEX | -1.5% |
-2.6% |
17.8% |
LYKA LABS related INDICES
You may also like the below Video Courses
FAQ about LYKA LABS Financials
How the annual revenues of LYKA LABS have changed ?
The Revenues of LYKA LABS have increased by 125.02% YoY .
How the Earnings per Share (EPS) of LYKA LABS have changed?
The Earnings Per Share (EPS) of LYKA LABS has decreased by Negative YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs